APEX1 and gastric cancer: Kaplan-Meier survival analysis showed APE1 positive expression associated with shorter overall and relapse free survival of seventy-five Her-2 positive patients with gastric cancer under 5-FU based treatment (logrank P = 0.009 and 0.02, respectively) (Figure 5A and 5B).